BCAL DIAGNOSTICS LTD宣布与Clearnote公司达成分销协议,将在澳大利亚和新西兰市场推广Clearnote的胰腺癌和卵巢癌血液检测产品。
BCAL DIAGNOSTICS LTD宣布与Clearnote公司达成分销协议,将在澳大利亚和新西兰市场推广Clearnote的胰腺癌和卵巢癌血液检测产品。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.